Evolution of the Average Target: CME Group Inc.

Evolution of the Target Price: CME Group Inc.

Changes in Analyst Recommendations: CME Group Inc.

37ced6457f2da8.LXK5H0y-KIo6IGm_lWKvYtEk5NE3BzI6J3-KYNgLJBA.ZRqJTCfYW_NKbCXlzTHKJ5Jyj6F0VkVrUkvYAbpmYHhXN-5cH-Fu5l1tCg~4175170c2508ad91542d8584f09a06aa
04/03 Argus Downgrades CME to Hold From Buy MT
02/03 Jefferies Adjusts Price Target on CME Group to $356 From $302, Maintains Buy Rating MT
12/02 Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating MT
11/02 Autonomous Research Adjusts Price Target on CME Group to $339 From $327, Maintains Outperform Rating MT
09/02 Goldman Sachs Adjusts Price Target on CME Group to $266 From $264, Maintains Sell Rating MT
07/02 CME Group says metals settlements delay resolved RE
06/02 UBS Adjusts CME Group Price Target to $310 From $280, Maintains Neutral Rating MT
05/02 Deutsche Bank Adjusts CME Group Price Target to $316 From $312, Maintains Buy Rating MT
05/02 JPMorgan Adjusts Price Target on CME Group to $266 From $262, Maintains Underweight Rating MT
05/02 TD Cowen Adjusts Price Target on CME Group to $328 From $305, Maintains Buy Rating MT
05/02 Barclays Adjusts Price Target on CME Group to $312 From $304, Maintains Equalweight Rating MT
05/02 RBC Raises Price Target on CME Group to $302 From $295, Keeps Sector Perform Rating MT
04/02 Raymond James Adjusts CME Group Price Target to $310 From $311, Maintains Outperform Rating MT
22/01 JPMorgan Adjusts CME Group Price Target to $262 From $256, Maintains Underweight Rating MT
14/01 BofA Adjusts Price Target on CME Group to $229 From $209 MT
14/01 Goldman Sachs Adjusts CME Group Price Target to $264 From $265, Maintains Sell Rating MT
14/01 Morgan Stanley Adjusts Price Target on CME Group to $319 From $320, Maintains Overweight Rating MT
14/01 TD Cowen Upgrades CME Group to Buy From Hold, Adjusts Price Target to $305 From $290 MT
12/01 Jefferies Adjusts Price Target on CME Group to $302 From $304, Maintains Buy Rating MT
05/01 Raymond James Adjusts PT on CME Group to $311 From $307, Maintains Outperform Rating MT
05/01 Autonomous Research Adjusts Price Target on CME Group to $327 From $322, Maintains Outperform Rating MT
22/12 Morgan Stanley Adjusts Price Target on CME Group to $320 From $314, Maintains Overweight Rating MT
17/12 Deutsche Bank Adjusts Price Target on CME Group to $318 From $310, Maintains Buy Rating MT
12/12 Barclays Adjusts CME Group Price Target to $304 From $280, Maintains Equalweight Rating MT
10/12 BofA Securities Adjusts CME Group Price Target to $209 From $201 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-0.37%
+5.56%
+8.88%
-5.78%
+10.58%
+17.87%
+26.79%
+23.34%
+27.86%
- - +42.91%
Average +15.76%
Weighted average by Cap. +3.83%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
303.33USD
Average target price
305.21USD
Spread / Average Target
+0.62%
High Price Target
356.00USD
Spread / Highest target
+17.36%
Low Price Target
232.00USD
Spread / Lowest Target
-23.52%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Argus
Jefferies & Co.
Rothschild & Co Redburn
Autonomous Research
Goldman Sachs
UBS
Deutsche Bank Securities
JPMorgan Chase
TD Cowen
Barclays
RBC Capital Markets
Raymond James
BofA Securities
Morgan Stanley
Piper Sandler
Keefe Bruyette & Woods
Citigroup
Oppenheimer
Redburn Atlantic
Rosenblatt Securities
Keefe, Bruyette & Woods
Credit Suisse
Atlantic Equities
Berenberg Bank
Wells Fargo Securities
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
303.33USD
Average target price
305.21USD
Spread / Average Target
+0.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CME Stock
  4. Consensus CME Group Inc.
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW